Michael White

Assistant Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael White is an Assistant Professor at The University of Texas MD Anderson Cancer Center Division of Surgery in the United States. His research focuses on colorectal cancer, with particular attention to proteotranscriptomic analyses, genomic landscapes, and treatment strategies, as highlighted in his recent articles. Dr. White is dedicated to advancing understanding and improving outcomes in patients with colorectal carcinomatosis and related conditions.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (14)

Norman Galbraith

University of Glasgow

UNITED KINGDOM

View details

Jason Willis

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Eric Lau

Associate Professor

Knight Cancer Institute, Oregon Health and Science University

UNITED STATES

View details

J. Bryan Iorgulescu

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Sarah Schneider

Texas Heart Institute

UNITED STATES

View details

Kjersti Flatmark

Oslo University Hospital

NORWAY

View details

Parker Institute for Cancer Immunotherapy

UNITED STATES

View details

Manoj Chelvanambi

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

keith fournier

Associate Professor of Surgery

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael White

Research Interests

Explore related searches

Contact this professor

About

Articles (27)

Proteotranscriptomic Analyses of Microsatellite-Stable Early-Onset Colorectal Cancer

Tumoral and circulating genomic landscape inform survival differences in colorectal carcinomatosis

ASO Author Reflections: What the Eye Cannot See

ASO Visual Abstract: Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis

Peritoneal Cancer Index Correlates with Radiographic Assessment of Colorectal Carcinomatosis

The Landscape of ctDNA in Appendiceal Adenocarcinoma

HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival

Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes.

Total Neoadjuvant Therapy for Rectal Cancer: Which Regimens to Use?

Defining the subset of mutations in polymerase epsilon (POLE) associated with loss-of-proofreading (LOP) functionality.

Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers.

Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer.

Androgen drives melanoma invasiveness and metastatic spread by inducing tumorigenic fucosylation.

The current multidisciplinary management of rectal cancer.

Assessing Disease Control in Mismatch Repair-Proficient Colorectal Cancer With Peritoneal Metastases Treated With Immune Checkpoint Blockade-Based Combination Therapies

Utility of Circulating Tumor DNA in Appendiceal Tumors

Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols

Young-onset Rectal Cancer: Unique Tumoral Microbiome and Correlation with Response to Neoadjuvant Therapy.

Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma

Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit.

ASO Visual Abstract: Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms.

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Stapled Versus Hand-Sewn Anastomosis in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanoma.

Collaborators (14)

Norman Galbraith

Jason Willis

Eric Lau

J. Bryan Iorgulescu

Sarah Schneider

Kjersti Flatmark

Elizabeth Burton

Stephanie Watowich

Reed Ayabe

Jenny Li

Alexandria Cogdill

Christine Spencer

Manoj Chelvanambi

keith fournier

Make your next move.